Filing Flows › Balchem (BCPC) › Q4 2025
Balchem (BCPC) Q4 2025 earnings results (fourth quarter 2025)
10-K filed Feb 20, 2026
Balchem (BCPC) reported revenue of $264M for the fourth quarter 2025 (Q4 2025), +10% from a year earlier and -1% from the quarter before. Operating margin was 19.8%, net earnings $39.2M (14.9% of revenue).
Balchem, Q4 2025: revenue $264M (+10% year over year), operating margin 19.8%, net earnings $39.2M, operating cash flow $67.3M. The chart follows the revenue to costs, profit and cash.
| Q4 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $264M | -1% | +10% |
| Gross profit | $93.9M | -2% | +9% |
| Operating profit | $52.3M | -4% | +10% |
| Net earnings | $39.2M | -3% | +17% |
| Operating cash flow | $67.3M | +3% | +29% |
| Free cash flow | $51.2M | — | +29% |
What changed
Revenue was $263.6M in Q4 2025, up 10% year over year and down 1% from the previous quarter. Product Sales Revenue was the largest line at 100% of revenue.
Gross margin was 35.6%, down 0.4 points from a year earlier. Operating profit was $52.3M, a 19.8% margin (up 0.1 points year over year). Of the extra revenue versus a year earlier, 21% reached operating profit, above the 20% margin then. Operating expenses grew 7% against revenue growth of 10%. The fastest-growing cost line was Sales & marketing (+17%). Net earnings were $39.2M, up 17% year over year. The effective tax rate was 21.6%.
Operating cash flow was $67.3M (up 29% year over year), 172% of net earnings. Non-cash charges added back $11.7M of depreciation and amortization and $3.8M of share-based compensation. Working capital and other items added $12.6M. After capital expenditures and proceeds from the sale of assets ($16.1M), free cash flow as the company reports it was $51.2M.
Questions
What was Balchem's revenue in the fourth quarter 2025?
Balchem (BCPC) reported revenue of $264M for the fourth quarter 2025 (Q4 2025), +10% from a year earlier and -1% from the quarter before.
Was Balchem profitable in the fourth quarter 2025?
Operating profit was $52.3M (19.8% of revenue) and net earnings $39.2M.
Source: Balchem 10-K on SEC EDGAR.